All stocks Β· POLYMED
PM

Poly Medicure Ltd

POLYMED BSE Healthcare

Poly Medicure Limited engages in the manufacture and sale of medical devices in India and internationally. The company offers infusion therapy products, including I.V Infusion set, extension lines, needle free connector…

ISIN INE205C01021
Listed β€”
Quarters tracked 13
Filings 20 docs

About

Poly Medicure Limited engages in the manufacture and sale of medical devices in India and internationally. The company offers infusion therapy products, including I.V Infusion set, extension lines, needle free connector, I.V flow regulator extension set, burette set, three way stop cock, vial access spike, transfer spike, orburator, polyflush, maifolds, polyswab, and arterial blood collection; critical care products, including vial access spikes, arterial cannula, mini mid lines over the wire, extension line, enteral connector, central venous catheters, and huber needle; dialysis and renal care products, comprising peritoneal dialysis set, haemocent, standard and safety fistula needle, dialyzer, bloodlines and dialysis system. It also provides cardiology products PTFE wire, inflation device, Y-connector, manifold, introducer, IV Cannula, hydrophilic wire, guiding catheter, drug eluting stent, PTCA balloon dilation catheter, diagnostic catheter, and electrocardiograph electrodes; vaccular access products; oncology products; diagnostics products, including blood collection tubes, safety blood collection set, blood collection needles, and standard needle holder. In addition, the company offers transfusion system products, including blood bags, blood administration set, and others; anesthesia and respiratory care products, comprising variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, aerosol therapy masks, ventilator circuits, suction catheters, spinal needle, polyciser, oxygen catheter, nebulizer compressor system, twin bore nasal oxygen cannula mucus extractor, HME filter, oro-pharyngeal airways, endotracheal tubes, catheter mount, and brain circuit; urology products, including urine collection bags, leg bag set, irrigation sets, and foley balloon and urine drainage catheters; wound drainage; and gastroenterology products. The company was incorporated in 1995 and is based in New Delhi, India.

Key Metrics

as of Sep 2026
Market Cap17,254 Cr
P/E53.90
Div Yield0.21 %
Book Valueβ‚Ή306.00
52w Highβ‚Ή2,110.00
52w Lowβ‚Ή1,182.00
Face Valueβ‚Ή5.00

Quarterly Results

Rs. Crores Β· hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 525.00 535.00 494.00 444.00 403.00 441.00 424.00 420.00 385.00 378.00 340.00 337.00 321.00
Expenses 400.00 424.00 382.00 329.00 298.00 321.00 310.00 305.00 281.00 282.00 249.00 253.00 234.00
Operating Profit 125.00 110.00 111.00 115.00 106.00 119.00 114.00 115.00 104.00 96.00 90.00 84.00 87.00
OPM % 24.00 21.00 23.00 26.00 26.00 27.00 27.00 27.00 27.00 26.00 27.00 25.00 27.00
Other Income 35.00 19.00 21.00 35.00 43.00 27.00 24.00 27.00 17.00 15.00 17.00 15.00 14.00
Depreciation 36.00 38.00 29.00 25.00 23.00 21.00 21.00 21.00 20.00 16.00 16.00 16.00 16.00
Interest 6.00 6.00 6.00 3.00 3.00 2.00 3.00 3.00 3.00 3.00 3.00 2.00 2.00
Profit before tax 117.00 85.00 98.00 122.00 123.00 123.00 113.00 118.00 98.00 92.00 88.00 81.00 83.00
Tax % 27.00 24.00 27.00 25.00 24.00 25.00 25.00 26.00 25.00 26.00 26.00 23.00 24.00
Net Profit 85.00 65.00 71.00 92.00 93.00 92.00 85.00 87.00 74.00 68.00 65.00 62.00 63.00
EPS in Rs 8.49 6.54 7.00 9.06 9.19 9.06 8.41 8.63 7.71 7.12 6.78 6.48 6.54

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Sales 1,875.001,669.001,375.001,115.00922.00785.00687.00610.00519.00454.00411.00390.00
Expenses 1,429.001,213.001,014.00847.00707.00569.00520.00479.00397.00361.00323.00304.00
Operating Profit 446.00456.00361.00267.00215.00216.00166.00131.00122.0093.0088.0086.00
OPM % 24.0027.0026.0024.0023.0028.0024.0022.0023.0021.0021.0022.00
Other Income 119.0094.0060.0038.0040.0022.0021.0020.0016.0014.008.0028.00
Interest 21.0014.0014.0011.006.0011.0020.0014.0012.008.0010.0010.00
Depreciation 116.0083.0063.0057.0054.0048.0041.0037.0029.0024.0021.0019.00
Profit before tax 427.00453.00344.00237.00195.00180.00126.00100.0097.0075.0065.0085.00
Tax % 25.0025.0025.0025.0025.0025.0024.0035.0027.0027.0027.0027.00
Net Profit 321.00339.00258.00179.00147.00136.0096.0065.0071.0055.0048.0062.00
EPS in Rs 31.7833.4126.9118.6915.2814.1710.867.418.006.255.477.07
Dividend Payout % 11.0010.0011.0016.0016.0018.0018.0027.0025.0040.0027.0018.00

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Equity Capital 51.0051.0048.0048.0048.0048.0044.0044.0044.0044.0022.0022.00
Reserves 3,055.002,715.001,422.001,194.001,040.00918.00391.00337.00294.00227.00207.00174.00
Borrowings 354.00180.00174.00149.00127.00137.00207.00161.00133.00101.0082.0079.00
Other Liabilities 401.00246.00215.00187.00163.00121.00126.00112.0094.0085.0076.0089.00
Total Liabilities 3,861.003,192.001,859.001,577.001,377.001,224.00767.00654.00565.00457.00387.00364.00
Fixed Assets 1,694.001,084.00867.00635.00488.00426.00363.00306.00265.00207.00182.00165.00
CWIP 99.00101.0076.0078.0043.0021.0025.0019.0018.0020.0014.0010.00
Investments 755.001,076.00167.00126.00346.00354.0025.008.0017.003.004.004.00
Other Assets 1,313.00930.00748.00738.00499.00422.00354.00321.00264.00227.00187.00185.00
Total Assets 3,861.003,192.001,859.001,577.001,377.001,224.00767.00654.00565.00457.00387.00364.00

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Cash from Operating Activity 246.00233.00266.00191.00123.00119.00131.00106.0075.0056.0063.0063.00
Cash from Investing Activity -224.00-1,187.00-241.00-179.00-85.00-436.00-109.00-101.00-88.00-56.00-31.00-59.00
Cash from Financing Activity 20.00951.00-20.00-13.00-35.00317.00-21.00-5.0016.000.00-31.00-6.00
Net Cash Flow 43.00-3.005.00-1.003.000.001.001.003.000.001.00-2.00
Free Cash Flow -59.00-97.00-9.00-48.00-31.0024.0025.0031.00-7.000.0031.0013.00
CFO/OP % 78.0071.0094.0093.0080.0075.00100.00102.0080.0079.0088.00101.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Debtor Days 103.0076.0072.0077.0082.0072.0068.0077.0079.0077.0074.0059.00
Inventory Days 323.00233.00205.00237.00218.00217.00241.00186.00161.00194.00114.00148.00
Days Payable 91.0070.0089.00105.00115.00111.00142.00123.0096.00131.0076.00101.00
Cash Conversion Cycle 335.00239.00188.00209.00185.00179.00166.00139.00144.00140.00111.00106.00
Working Capital Days 105.0075.0054.0069.0081.0074.0042.0056.0071.0055.0035.0025.00
ROCE % 12.0018.0024.0018.0017.0022.0025.0022.0026.0024.0026.0030.00

Shareholding Pattern

% holding β€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 62.42 62.42 62.42 62.42 62.44 62.44 62.44 62.56 66.02 53.14 53.17 53.17
FIIs 5.56 5.92 9.41 9.77 11.41 11.46 12.33 11.88 9.91 12.37 14.10 14.49
DIIs 16.08 15.60 13.84 13.53 11.72 11.96 11.66 12.33 9.34 7.21 5.46 5.15
Public 15.94 16.08 14.34 14.28 14.43 14.13 13.57 13.23 14.72 27.25 27.28 27.20
No. of Shareholders 73,643 73,414 67,750 64,400 71,142 65,583 60,686 38,352 36,852 36,712 36,053 34,649

Corporate Actions

28 records
ActionEx DateRecord DateRatioAmount (β‚Ή)Notes
Dividend 18 Sep 2025 18 Sep 2025 β€” 3.50
Dividend 19 Sep 2024 β€” β€” 3.00
Dividend 21 Sep 2023 β€” β€” 3.00
Dividend 16 Sep 2022 β€” β€” 2.50
Dividend 16 Sep 2021 17 Sep 2021 β€” 2.50
Other 16 Sep 2021 β€” β€” β€” Annual General Meeting
Other 21 Sep 2020 β€” β€” β€” Annual General Meeting
Dividend 27 Feb 2020 29 Feb 2020 β€” 2.00
Dividend 13 Sep 2019 β€” β€” 2.00
Dividend 18 Sep 2018 β€” β€” 2.00
Dividend 20 Sep 2017 β€” β€” 0.50
Bonus 24 Mar 2017 28 Mar 2017 1:1 β€”
Dividend 15 Feb 2017 16 Feb 2017 β€” 1.00
Dividend 11 Nov 2016 15 Nov 2016 β€” 1.00
Dividend 19 Sep 2016 β€” β€” 0.50
Dividend 17 Mar 2016 18 Mar 2016 β€” 2.50
Dividend 18 Sep 2015 β€” β€” 2.50
Split 02 Feb 2015 03 Feb 2015 10:5 β€”
Dividend 15 Sep 2014 β€” β€” 4.00
Dividend 19 Sep 2013 β€” β€” 2.00
Bonus 09 Jul 2013 10 Jul 2013 1:1 β€”
Dividend 13 Sep 2012 β€” β€” 3.00
Dividend 25 Aug 2011 β€” β€” 3.00
Dividend 24 Aug 2010 β€” β€” 2.50
Bonus 26 Mar 2010 29 Mar 2010 1:1 β€”
Dividend 21 Aug 2009 β€” β€” 2.50
Dividend 23 Aug 2007 β€” β€” 2.50
Dividend 08 Sep 2004 β€” β€” 1.50

Announcements

5 filings